---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-072457"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2023-12-22T23:59:59+00:00"
generated_at: "2026-06-07T07:47:47.469932+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences amends bylaws for universal proxy and nomination procedures

## Summary
- Board adopted amended bylaws on Dec 19, 2023, effective same day, addressing SEC universal proxy rules.
- New rules require compliance with Rule 14a-19 for proxy solicitations supporting non-Board nominees.
- Enhanced disclosure requirements for stockholder nominations and proposals, including derivative interests.
- Prohibits stockholders from submitting more director nominees than seats up for election.
- Requires proxy cards for dissident solicitations to be a color other than white.

## SEC filing metadata
- accession: 0000950170-23-072457
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2023-12-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017023072457/0000950170-23-072457-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017023072457/dtil-20231219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-072457
- JSON: https://secwatch.observer/filing/0000950170-23-072457.json
- Plain text: https://secwatch.observer/filing/0000950170-23-072457.txt

## Key facts
- Governance Changes
  PRECISION BIOSCIENCES INC: Amended and restated bylaws to address universal proxy rules, update stockholder nomination and proposal procedures, and make technical changes (effective 2023-12-19).
  - Change: bylaw amendment
  - Effective: 2023-12-19
  source text: On December 19, 2023, the Board of Directors (the “Board”) of Precision BioSciences, Inc. (the “Company”) approved and adopted amendments to the Company’s amended and restated bylaws (as amended, the “Amended and Restated Bylaws”), which became effective the same day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000095017023072457/0000950170-23-072457-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.